While our studies strongly suggest that Kindlin-2 regulates breast cancer progression through, at least in part, promotion of Src-mediated AR Tyr-534 phosphorylation, downstream signaling, our findings do not rule out the possibility that Kindlin-2 may participate in breast cancer progression through regulation of other pathways. Here, FERMT2 is linked to breast carcinoma.